A patient interface for delivery of a supply of pressurised air or breathable gas to an entrance of a patient's airways comprising: a cushion member that includes a retaining structure and a seal-forming structure permanently connected to the retaining structure; a frame member attachable to the retaining structure; and a positioning and stabilising structure attachable to the frame member.

Disclosed is a weighted material that is configured to effectuate deep pressure therapy to a person when the weighted material is used as a blanket over the person's body. A length of layered yarn is interlooped to form the weighted material. The layered yarn includes an outer tube extending longitudinally from a first end to a second end. The outer tube defines a conduit extending longitudinally therethrough from the first end to the second end. A fiber material is disposed within the conduit and extend longitudinally from the first end to the second end. The interlooped length of yarn, by itself, is configured and sufficiently weighted to effectuate deep pressure therapy to a person when the blanket lies over the person's body. Various other systems and methods are also disclosed.

Provided is a dental cord using a nanofiber multiple yarn having a large specific surface area and a large number of three-dimensional pores, thereby effectively impregnating a drug such as a hemostatic agent, and a method of manufacturing the dental cord. The dental cord includes: a nanofiber multiple yarn which is obtained by plying and twisting at least two nanofiber tape yarns and which is impregnated with a drug, wherein the at least two nanofiber tape yarns are integrated by nanofibers made of fiber moldability polymer materials and having an average diameter of less than 1 μm, to thus be formed of a nanofiber web having three-dimensional micropores.

A method is for the production of a scintillator fiber. In an embodiment, the method includes provisioning a suspension of a binder dissolved in a solvent and a scintillator material; and pressing the suspension into a precipitation bath in which the binder is insoluble.

Improved methods, designs and/or systems for incorporating markings and/or other visual and/or tactilely identifiable indicia on woven, knitted, nonwoven, braided and/or felted textiles used for medical textile implants and prostheses, including medical graft prostheses that would not affect the overall mechanical performance of the textile.

A polymer composition comprising a polymer and at least one active substance selected from the group consisting of a substance generating an occlusion, in particular a substance generating an internal occlusion or a substance generating an external occlusion; a moisturizing substance; a substance reducing pain or itching; and mixtures of these.

A three-dimensional electrospun biomedical patch includes a first polymeric scaffold having a first structure of deposited electrospun fibers extending in a plurality of directions in three dimensions to facilitate cellular migration for a first period of time upon application of the biomedical patch to a tissue, wherein the first period of time is less than twelve months, and a second polymeric scaffold having a second structure of deposited electrospun fibers. The second structure of deposited electrospun fibers includes the plurality of deposited electrospun fibers configured to provide structural reinforcement for a second period of time upon application of the three-dimensional electrospun biomedical patch to the tissue wherein the second period of time is less than twelve months. The three-dimensional electrospun biomedical patch is sufficiently pliable and resistant to tearing to enable movement of the three-dimensional electrospun biomedical patch with the tissue.

Actuators (artificial muscles) comprising twist-spun nanofiber yarn or twist-inserted polymer fibers generate torsional and/or tensile actuation when powered electrically, photonically, chemically, thermally, by absorption, or by other means. These artificial muscles utilize non-coiled or coiled yarns and can be either neat or comprising a guest. Devices comprising these artificial muscles are also described.

Fibrous structures and more particularly to fibrous structures that exhibit improved TEWL properties, for example lower TEWL % Difference Values as measured according to the TEWL Test Method described herein, compared to known fibrous structures, sanitary tissue products comprising such fibrous structures and method for making such fibrous structures are provided.

Layered, and optionally dispersible fibrous structures containing fibrous elements that exhibit different physical characteristics, such as different average diameters as measured by the Average Diameter Test Method described herein, different surface characteristics, different lengths, different sources (naturally occurring versus non-naturally occurring and/or spun versus non-spun), sanitary tissue products employing such layered, optionally dispersible fibrous structures, and methods for making same are provided.